NEW YORK STATE TEACHERS RETIREMENT SYSTEM - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW YORK STATE TEACHERS RETIREMENT SYSTEM ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$511
-5.0%
18,017
-2.2%
0.00%0.0%
Q4 2022$538
-99.9%
18,4170.0%0.00%0.0%
Q3 2022$487,000
-40.5%
18,4170.0%0.00%
-50.0%
Q2 2022$818,000
-10.2%
18,4170.0%0.00%0.0%
Q1 2022$911,000
-3.4%
18,417
-0.5%
0.00%0.0%
Q4 2021$943,000
-8.2%
18,517
+0.5%
0.00%0.0%
Q3 2021$1,027,000
+30.3%
18,4170.0%0.00%0.0%
Q2 2021$788,000
+2.5%
18,4170.0%0.00%0.0%
Q1 2021$769,000
-12.7%
18,417
-2.6%
0.00%0.0%
Q4 2020$881,000
+9.6%
18,9170.0%0.00%0.0%
Q3 2020$804,000
-12.3%
18,917
-1.0%
0.00%0.0%
Q2 2020$917,000
+3.3%
19,117
-1.0%
0.00%
-33.3%
Q1 2020$888,000
-23.4%
19,3080.0%0.00%0.0%
Q4 2019$1,160,000
+112.1%
19,308
+99.5%
0.00%
+200.0%
Q3 2019$547,000
+1.5%
9,6770.0%0.00%0.0%
Q2 2019$539,000
+10.2%
9,6770.0%0.00%0.0%
Q1 2019$489,000
+28.0%
9,677
+2.2%
0.00%0.0%
Q4 2018$382,000
-41.6%
9,469
+0.5%
0.00%
-50.0%
Q3 2018$654,000
-0.8%
9,426
+8.2%
0.00%0.0%
Q2 2018$659,000
+26.2%
8,715
-12.1%
0.00%
+100.0%
Q1 2018$522,000
+12.0%
9,915
+13.8%
0.00%0.0%
Q4 2017$466,000
-8.6%
8,715
+1.8%
0.00%0.0%
Q3 2017$510,000
-39.9%
8,557
-20.5%
0.00%
-50.0%
Q2 2017$849,000
+2.8%
10,757
+8.0%
0.00%0.0%
Q1 2017$826,000
+4.6%
9,9570.0%0.00%0.0%
Q4 2016$790,000
+15.7%
9,957
+2.0%
0.00%0.0%
Q3 2016$683,000
+2339.3%
9,757
+1293.9%
0.00%
Q1 2016$28,0007000.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 121,014$5,377,0001.78%
Smith, Graham & Co., Investment Advisors, LP 232,343$10,323,0001.28%
GLOBEFLEX CAPITAL L P 73,205$3,252,0000.79%
SummerHaven Investment Management, LLC 18,604$827,0000.56%
BRANDES INVESTMENT PARTNERS, LP 464,292$20,628,0000.50%
Capital Impact Advisors, LLC 11,728$521,0000.48%
Watershed Asset Management, L.L.C. 5,756$256,0000.32%
Foundry Partners, LLC 84,325$3,747,0000.23%
Summit Global Investments 33,738$1,499,0000.13%
SCOUT INVESTMENTS, INC. 147,034$6,533,0000.13%
View complete list of EAGLE PHARMACEUTICALS INC shareholders